Neurocrine Phase II insomnia results

NBIX said patients using NBI-34060 non-benzodiazepine GABA(A) receptor antagonist had 40% improvement on the primary endpoint of Latency to Persistent Sleep (LPS) scores (p<0.004) and improved Time to...